LFG
CVS icon

Lazard Frères Gestion’s CVS Health CVS Stock Holding History

Lazard Frères Gestion’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,075
Closed -$1.15M – 120
2026
Q1 		$1.15M Hold
16,075
– – 0.02% 80
2025
Q4 		$1.27M Sell
16,075
-75
-0.5% -$5.91K 0.02% 78
2025
Q3 		$1.22M Hold
16,150
– – 0.02% 80
2025
Q2 		$1.11M Hold
16,150
– – 0.02% 76
2025
Q1 		$1.09M Sell
16,150
-14,196
-47% -$850K 0.03% 73
2024
Q4 		$1.36M Buy
30,346
+500
+2% +$28.1K 0.03% 67
2024
Q3 		$1.88M Hold
29,846
– – 0.04% 58
2024
Q2 		$1.76M Buy
29,846
+650
+2% +$40.7K 0.04% 55
2024
Q1 		$2.33M Buy
29,196
+200
+0.7% +$15.3K 0.06% 48
2023
Q4 		$2.29M Buy
28,996
+50
+0.2% +$3.56K 0.07% 47
2023
Q3 		$2.02M Buy
28,946
+390
+1% +$27.6K 0.06% 47
2023
Q2 		$1.97M Buy
28,556
+24,475
+600% +$1.74M 0.06% 48
2023
Q1 		$257K Buy
+4,081
New +$342K 0.01% 72
2022
Q2 		– Sell
-277,997
Closed -$26.4M – 66
2022
Q1 		$26.4M Sell
277,997
-92,923
-25% -$9.76M 0.8% 38
2021
Q4 		$35.5M Buy
370,920
+2,601
+0.7% +$240K 0.96% 36
2021
Q3 		$31.3M Sell
368,319
-194
-0.1% -$16.3K 0.88% 36
2021
Q2 		$25.9M Sell
368,513
-78,661
-18% -$6.44M 0.84% 39
2021
Q1 		$28.6M Sell
447,174
-71,061
-14% -$5.18M 1% 36
2020
Q4 		$35.5M Buy
+518,235
New +$33.7M 1.13% 34

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Lazard Frères Gestion's CVS Position: Q2 2026 in Review

Lazard Frères Gestion sold out of CVS Health (CVS) in Q2 2026, closing a stake of 16,075 shares — an estimated $1.15M sold.

Lazard Frères Gestion first reported a position in CVS in Q4 2020 and held it in 19 quarters. The position peaked at $35.5M in Q4 2020. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Lazard Frères Gestion reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Lazard Frères Gestion sold 16,075 CVS Health shares in Q2 2026, an estimated $1.15M.
  • Lazard Frères Gestion first reported a position in CVS Health in Q4 2020 and held it in 19 quarters.
  • Lazard Frères Gestion's CVS Health position peaked at $35.5M in Q4 2020.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Lazard Frères Gestion's 13F filing for Q2 2026, filed 6 Aug 2026.